MEA Contrast Injector Market

Middle East & Africa Contrast Injector Market Size & Growth (2022 to 2027)

As per the research report, the size of the Middle East and Africa Contrast Injector Market is valued at USD 66.48 million in 2022 and is projected to grow at a CAGR of 5.73%, reaching USD 87.82 million by 2027 during the forecast period 2022 to 2027.

The necessity for minimally invasive operations is growing in the market, which is driving market expansion. Another crucial primary factor is that Contrast injectors are devices that control contrast material before diagnostic imaging techniques, improving the quality of the images obtained. These are the factors that drive the growth of the market.

Contrast injectors include functions such as preloaded procedures and safety measures to avoid extravasation by injection of contrast media to physicians, which is the fundamental reason for the market's success.

In addition, the injectors' quality contrast is significantly boosted since they limit the amount of contrast vision.

Furthermore, government and private sector investments in contrast injectors and the treatment and control of chronic diseases are likely to drive the MEA contrast injectors market forward. Moreover, manufacturers progressively strive to increase biodegradable injector manufacturing because of the necessity to ensure environmental sustainability.

The high cost of contrast injectors, consumables, and accessories would be a significant impediment to the growth of the MEA contrast injectors market over the forecast period.

Such adverse effects are expected to hinder the growth of the MEA contrast injectors industry.

This research report on the MEA Contrast Injector Market has been segmented and sub-segmented into the following categories.

By Product: 

• Injector Systems
• Consumables

By Application:

• Radiology
• Interventional Cardiology
• Interventional Radiology

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East & Africa Contrast injector Market holds a moderate share globally due to a rise in the senior population and an increase in the volume of diagnostic procedures; demand for contrast injector devices is increasing during the forecast period.

The UAE Contrast Injector Market is poised to emerge as a hotspot due to their highly developed healthcare facilities, improving healthcare infrastructure, and the increasing prevalence of chronic illnesses like orthopedic diseases, epilepsy, Alzheimer's disease, and cancer.

The Saudi Arabia Contrast Injector Market is predicted to grow significantly due to healthcare environments and technological advancements that aid in developing low-cost, fully automated contrast injector systems.

The South African Contrast Injector Market is projected to witness the highest CAGR due to technological advancements, resulting in sophisticated therapy options for managing chronic illnesses over the forecast period.

KEY MARKET PLAYERS

The leading companies dominating the MEA Contrast Injector Market profiled in the report are Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Guerbet Group (France), Medtronic AG (Germany), Ulrich GmbH & Co. KG (Germany), and Apollo RT Co., Ltd. (China).,